finance.yahoo.comWith 35% ownership, insiders at CervoMed Inc. (NASDAQ:CRVO) are pretty optimistic and have been buying recently11 months ago
finance.yahoo.comCervoMed Featured in Fortune for Advances in the Treatment of Dementia with Lewy Bodies12 months ago
finance.yahoo.comCervoMed Reports Second Quarter 2024 Financial Results and Provides Corporate Updates12 months ago
finance.yahoo.comCervoMed Announces Presentation at AAIC 2024 on Plasma Biomarker Data That Are Consistent with Neflamapimod Impacting the Underlying Disease Process in Patients with Dementia with Lewy bodies (DLB)about 1 year ago
benzinga.comCervoMed to Host Virtual KOL Event on Neflamapimod for Dementia with Lewy Bodies on July 23, 2024about 1 year ago
finance.yahoo.comCervoMed (NASDAQ:CRVO) Is In A Good Position To Deliver On Growth Plansabout 1 year ago
finance.yahoo.comCervoMed Announces Completion of Enrollment in Phase 2b RewinD-LB Clinical Trial of Neflamapimod for the Treatment of Patients with Dementia with Lewy Bodiesabout 1 year ago
benzinga.comWhy Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Sessionabout 1 year ago
CashuCervoMed's Promising Trial Results Advance Dementia Treatment with Neflamapimod for DLB.6 days ago